Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03673046 · ClinicalTrials.gov registry record · NA
Waitlist-Control Trial of Smartphone Cognitive Behavioral Therapy (CBT) for Body Dysmorphic Disorder (BDD)
A NA study of Body Dysmorphic Disorder, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT03673046: Completed NA study of Body Dysmorphic Disorder, sponsored by Massachusetts General Hospital.
NCT03673046 is a NA study of Body Dysmorphic Disorder that has completed, run by Massachusetts General Hospital. The registered enrollment target is 80 participants, below the 142-participant average among 3 other Body Dysmorphic Disorder trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03673046, a NA study of Body Dysmorphic Disorder, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are testing the efficacy of Smartphone-delivered cognitive behavioral therapy (CBT) treatment for body dysmorphic disorder (BDD). The investigators hypothesize that participants receiving app-CBT will have greater improvement in body dysmorphic disorder symptom severity than those in the waitlist condition at treatment endpoint (week 12).
Primary Outcome
The BDD Yale-Brown Obsessive Compulsive Scale (BDD-YBOCS) is the gold-standard, semi-structured clinician-administered assessment of BDD severity. It contains 12 items ranging from 0 to 4, which are summed to generate a total score (range = 0 to 48). Higher scores indicate more severe BDD symptoms. The BDD-YBOCS
Conditions Studied
Interventions
- DEVICE Smartphone-delivered cognitive behavioral therapy (CBT) for body dysmorphic disorder (BDD)
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2019-09-17 |
| Est. Completion | 2022-10-03 |
| Phase | NA |
What the finished NCT03673046 record still lists
NCT03673046 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 142-participant average among 3 other Body Dysmorphic Disorder trials with a reported enrollment target (44% lower).
The record links to 1 condition, with Body Dysmorphic Disorder appearing as the primary indexed condition, and to 1 intervention - of which Smartphone-delivered cognitive behavioral therapy (CBT) for body dysmorphic disorder (BDD) is the first listed.
NCT03673046 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03673046 about?
NCT03673046 is a clinical study titled "Waitlist-Control Trial of Smartphone Cognitive Behavioral Therapy (CBT) for Body Dysmorphic Disorder (BDD)". The investigators are testing the efficacy of Smartphone-delivered cognitive behavioral therapy (CBT) treatment for body dysmorphic disorder (BDD). The investigators hypothesize that participants receiving app-CBT will have greater improvement in body dysmorphic disorder symptom severity than those ...
What is the current status of trial NCT03673046?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2019-09-17. Estimated completion is 2022-10-03.
What conditions does trial NCT03673046 study?
This clinical trial studies the following conditions: Body Dysmorphic Disorder.
What interventions are being tested in trial NCT03673046?
The interventions under investigation include: Smartphone-delivered cognitive behavioral therapy (CBT) for body dysmorphic disorder (BDD) (DEVICE).
Who is sponsoring clinical trial NCT03673046?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03673046 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Body Dysmorphic Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI